CY1112482T1 - Ποσοτικος προσδιορισμος σχεδον πληρους γονιδιωματος για αντισταση εναντιον φαρμακου κατα toy hcv - Google Patents

Ποσοτικος προσδιορισμος σχεδον πληρους γονιδιωματος για αντισταση εναντιον φαρμακου κατα toy hcv

Info

Publication number
CY1112482T1
CY1112482T1 CY20111100494T CY111100494T CY1112482T1 CY 1112482 T1 CY1112482 T1 CY 1112482T1 CY 20111100494 T CY20111100494 T CY 20111100494T CY 111100494 T CY111100494 T CY 111100494T CY 1112482 T1 CY1112482 T1 CY 1112482T1
Authority
CY
Cyprus
Prior art keywords
hcv
geneum
complete
quantitative determination
medicine resistance
Prior art date
Application number
CY20111100494T
Other languages
English (en)
Inventor
Grégoire Vuagniaux
Jean-Maurice Dumont
Joke Snoeck
Dooren Sonia Van
Anne-Mieke Vandamme
Original Assignee
Debiopharm S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debiopharm S.A. filed Critical Debiopharm S.A.
Publication of CY1112482T1 publication Critical patent/CY1112482T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η εφεύρεση αφορά ποσοτικούς προσδιορισμούς για τον χαρακτηρισμό γονοτυπικών μεταλλάξεων του ιού ηπατίτιδας C (HCV), οι οποίες επιδεικνύουν μια αντίσταση εναντίον φαρμάκων κατά του HCV.
CY20111100494T 2007-10-31 2011-05-20 Ποσοτικος προσδιορισμος σχεδον πληρους γονιδιωματος για αντισταση εναντιον φαρμακου κατα toy hcv CY1112482T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2007003304 2007-10-31
EP08844624A EP2215272B1 (en) 2007-10-31 2008-10-31 Near full-genome assay of hcv drug resistance

Publications (1)

Publication Number Publication Date
CY1112482T1 true CY1112482T1 (el) 2015-12-09

Family

ID=40466927

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100494T CY1112482T1 (el) 2007-10-31 2011-05-20 Ποσοτικος προσδιορισμος σχεδον πληρους γονιδιωματος για αντισταση εναντιον φαρμακου κατα toy hcv

Country Status (17)

Country Link
US (2) US8911934B2 (el)
EP (1) EP2215272B1 (el)
JP (1) JP5607532B2 (el)
AT (1) ATE499451T1 (el)
AU (1) AU2008320529B2 (el)
CA (1) CA2703765A1 (el)
CY (1) CY1112482T1 (el)
DE (1) DE602008005188D1 (el)
DK (1) DK2215272T3 (el)
ES (1) ES2361598T3 (el)
HR (1) HRP20110347T1 (el)
NZ (1) NZ585282A (el)
PL (1) PL2215272T3 (el)
PT (1) PT2215272E (el)
RS (1) RS51849B (el)
SI (1) SI2215272T1 (el)
WO (1) WO2009056966A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012177739A2 (en) * 2011-06-20 2012-12-27 Siemens Healthcare Diagnostics Inc. Reagents and methods for detecting hcv
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874565A (en) * 1995-08-29 1999-02-23 Washington University Nucleic acids comprising a highly conserved novel 3 terminal sequence element of the hepatitis C virus
US7829693B2 (en) * 1999-11-24 2010-11-09 Alnylam Pharmaceuticals, Inc. Compositions and methods for inhibiting expression of a target gene
US6368801B1 (en) * 2000-04-12 2002-04-09 Molecular Staging, Inc. Detection and amplification of RNA using target-mediated ligation of DNA by RNA ligase
EP1379690A4 (en) 2001-04-12 2004-08-18 Biocore Co Ltd OLIGONUCLEOTIDE CHIP COMPOSITION FOR THE ANALYSIS OF THE HEPATITIS C VIRUS GENOTYPE (HCV), AND DETECTION METHOD THEREOF
ES2386742T3 (es) * 2002-03-11 2012-08-28 Lab 21 Limited Método y composiciones para identificar y caracterizar la Hepatitis C
US8481506B2 (en) * 2006-12-05 2013-07-09 Rosetta Genomics, Ltd. Nucleic acids involved in viral infection
US8614198B2 (en) * 2007-06-22 2013-12-24 Alnylam Pharmaceuticals, Inc. Hepatitis C dsRNA effector molecules, expression constructs, compositions, and methods of use

Also Published As

Publication number Publication date
ES2361598T3 (es) 2011-06-20
HRP20110347T1 (hr) 2011-07-31
AU2008320529B2 (en) 2013-10-24
WO2009056966A1 (en) 2009-05-07
US8911934B2 (en) 2014-12-16
PL2215272T3 (pl) 2011-08-31
NZ585282A (en) 2012-03-30
SI2215272T1 (sl) 2011-08-31
EP2215272B1 (en) 2011-02-23
JP5607532B2 (ja) 2014-10-15
JP2011501957A (ja) 2011-01-20
EP2215272A1 (en) 2010-08-11
ATE499451T1 (de) 2011-03-15
DK2215272T3 (da) 2011-06-06
AU2008320529A1 (en) 2009-05-07
RS51849B (en) 2012-02-29
US20140187765A1 (en) 2014-07-03
CA2703765A1 (en) 2009-05-07
DE602008005188D1 (de) 2011-04-07
US20100311038A1 (en) 2010-12-09
PT2215272E (pt) 2011-05-23

Similar Documents

Publication Publication Date Title
HK1138297A1 (en) Human antibodies against hepatitis c virus (hcv) uses thereof (hcv)
GB0718984D0 (en) Structure of the hepatitis C virus NS5A protein
DK1831357T3 (da) Genvinding af influenzavirus
CL2009000305A1 (es) Compuestos derivados de 2-aril-sustituido-1-benzofurano-3-carboxamida, inhibidores de la polimerasa ns5b; composicion farmaceutica; y su uso en el tratamiento de una enfermedad causada por el virus de la hepatitis c (hcv).
CY2015004I1 (el) Αναστολεις του ιου της ηπατιτιδας c
EA201190013A1 (ru) Ингибиторы ns5a вгс
ATE474827T1 (de) Hcv-replikationshemmer
BRPI0821252A2 (pt) Anticorpos ao vírus da hepatite c
DK1912999T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
DK1912997T3 (da) Makrocycliske inhibitorer af hepatitis C virus
DK1919898T3 (da) Makrocykliske inhibitorer af hepatitis-C-virus
DK1912996T3 (da) Makrocykliske inhibitorer af hepatitis C-virus
DK1912981T3 (da) Makrocykliske inhibitorer af Hepatitis C-virus
DK1912995T3 (da) Makrocykliske inhibitorer af hepatitis C virus
DK1919899T3 (da) Makrocykliske inhibitorer af hepatitis C virus
DK1913014T3 (da) Makrocykliske inhibitorer af hepatitis-c-virus
NO20091871L (no) Hepatitt C virus inhibitorer
DK2238142T3 (da) Makrocykliske indoler som hepatitis C-virusinhibitorer
ATE492558T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
EP1716250A4 (en) DETERMINATION OF THE HEPATITIS C VIRUS GENOTYP
ATE492559T1 (de) Makrocyclische peptide als hepatitis-c-virus- hemmer
CY1112482T1 (el) Ποσοτικος προσδιορισμος σχεδον πληρους γονιδιωματος για αντισταση εναντιον φαρμακου κατα toy hcv
EP1982728A4 (en) HEPATITIS C-VIRUS DERIVED PEPTIDE
SI2203430T1 (sl) N-fenil-diokso-hidropirimidini, uporabni kot inhibitorji virusa hepatitisa C (HCV)